Review ArticleHigh-Flow Nasal Cannula Oxygen in Adult Patients: A Narrative Review☆
Section snippets
Study Objectives
The goal of this review is to summarize the relevant medical literature on the use of HFNC in adults. Several reviews are available for the pediatric population, and these articles will not be included in our analysis.1 We will try to answer the following key questions about the use of HFNC in adults.
- 1.
What are the usual physiological changes seen in patients with the use of HFNC?
- 2.
In which patients and clinical settings has HFNC been studied?
- 3.
Does it help patients avoid the use of NIV or intubation
RESULTS
Fifteen studies met our inclusion criteria and were analyzed. Five studies were randomized studies (Table 1), 5 were nonrandomized prospective studies (Table 2) and 5 were retrospective cohort studies. These studies included 943 patients managed in intensive care units (ICUs) (9 studies), emergency departments (1 study), postoperative units (4 studies) and inpatient hospital services (1 study also with some ICU patients). Frequent diagnoses included postoperative patients (410 patients), cancer
DISCUSSION
HFNC provides higher gas flow rates with higher FiO2s than conventional O2 supplementation with nasal cannulas, face masks, Venturi masks and non-rebreathing masks. Therefore, these devices increase O2 delivery and improve PaO2 in hypoxemic patients and potentially obviate the need for positive pressure ventilation. In addition, the high flow rates can create a slightly positive pressure in the upper airway similar to nasal CPAP.2., 3. This technique has been widely studied in pediatric
CONCLUSIONS
Studies with HFNC in adults have demonstrated that this technology can provide supplemental oxygen at higher flows and FiO2 than conventional O2 delivery methods in patients with acute hypoxemic respiratory failure. These studies demonstrate that HFNC increases the PaO2 in these patients, is well tolerated and has few side effects. However, it is important to conduct studies that are adequately powered to determine which patient groups benefit the most with HFNC. In particular, clinicians need
RECOMMENDATIONS
- 1.
HFNC delivery systems are most useful in patients with hypoxemic respiratory failure who are difficult to oxygenate with face masks and/or nasal cannulas (Figure 2). These patients must have an adequate respiratory drive and muscle strength to maintain reasonable minute ventilations and keep their PaCO2 from increasing rapidly.
- 2.
Patients should have a reduction in respiratory rate and dyspnea and should have an increase in PaO2 or O2 saturation after switching to HFNC.
- 3.
Potential candidates include
REFERENCES (26)
- et al.
Research in high flow therapy: mechanisms of action
Respir Med
(2009) - et al.
High-flow nasal oxygen vs high-flow face mask: a randomized crossover trial in extubated patients
J Crit Care
(2010) - et al.
Open-label, phase II study of routine high-flow nasal oxygen therapy in cardiac surgical patients
Br J Anaesth
(2013) - et al.
Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients
Br J Anaesth
(2011) - et al.
High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v
J Crit Care
(2012) - et al.
High-Flow therapy via nasal cannula in acute heart failure
Rev Esp Cardiol
(2011) - et al.
High flow nasal oxygen generates positive airway pressure in adult volunteers
Aust Crit Care
(2007) - et al.
Nasal high-flow therapy delivers low level positive airway pressure
Br J Anaesth
(2009) - et al.
The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease
Chest
(2004) - et al.
Patients with New York Heart Association class III heart failure may benefit with high flow nasal cannula supportive therapy. High flow nasal cannula in heart failure
J Crit Care
(2013)
Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature
Intensive Care Med
High flow nasal oxygen in acute respiratory failure
Minerva Anestesiol
A preliminary randomized controlled trial to assess effectiveness of nasal high-flow oxygen in intensive care patients
Resp Care
Cited by (36)
High-flow nasal oxygen is not an oxygen therapy device
2017, Revista Portuguesa de Pneumologia (English Edition)New approaches to the treatment of respiratory failure: High flow therapy
2016, Medicina ClinicaComparison of high-flow nasal oxygen therapy with conventional oxygen therapy and noninvasive ventilation in adult patients with acute hypoxemic respiratory failure: A meta-analysis and systematic review
2016, Journal of Critical CareCitation Excerpt :Flow, on the other hand, is set equal to or greater than the patient's inspiratory flow demand and titrated to the work of breathing [16]. But the role of HFNO in ARF is an open question, and the recent reviews [15,17] of HFNO have not dealt with this in detail. Although the results of RCTs have been inconsistent regarding escalation of respiratory support, this meta-analysis shows that there is a trend toward improved outcomes with HFNO compared with standard oxygen therapy, which is not statistically significant.
- ☆
The authors have no financial or other conflicts of interest to disclose.